In other words ...
Dr. Schold’s research interests include development and impact of quality metrics for healthcare providers, health services research, disparities in access to healthcare and statistical and epidemiological methods. He oversees the ongoing monitoring and quality evaluation of the solid organ transplantation programs at the Cleveland Clinic and has special interest in the development and use of report cards in transplantation.
Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR. Building an Ideal Quality Metric for ESRD Healthcare Delivery. Clinical Journal of the American Society of Nephrology. 2017 Aug; 12(8): 1351-56.
Navaneethan S, Schold J, Jolly S, Arrigain S, Blum M, Winkelmayer W, Nally J. Blood Pressure Parameters are Associated with All-cause and Cause-specific Mortality in Chronic Kidney Disease. Kidney International. 2017 Nov; 92(5): 1272-81.
Rodrigue JR, Fleishman A, Carroll M, Evenson AR, Pavlakis M, Mandelbrot DA, Baliga P, Howard DH, Schold JD. The Living Donor Lost Wages Trial: Study Rationale and Protocol. Current Transplantation Reports. 2018 Mar; 5(1): 45-54.
Schold JD, Poggio ED, Augustine JJ. Gathering Clues to Explain the Stagnation in Living Donor Kidney Transplantation in the United States. American Journal of Kidney Diseases. 2018 May; 71(5): 608-10.
Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Mood, Body Image, Fear of Kidney Failure, Life Satisfaction and Decisional Stability Following Living Kidney Donation: Findings from the KDOC Study. American Journal of Transplantation. 2018 Jun; 18(6): 1397-1407.
Schold JD, Andreoni KA, Chandraker AK, Gaston RS, Locke JE, Mathur AK, Pruett T, Rana A, Ratner LE, Buccini LD. Expanding Clarity or Confusion? Volatility of the Five-tier Ratings Assessing Quality of Transplant Centers in the United States. American Journal of Transplantation. 2018 Jun: 18(6): 1494-1501.
Schold JD, Flechner SM, Poggio ED, Augustine J, Goldfarb DA, Sedor JR, Buccini LD. Residential Area Life Expectancy: Association with Outcomes and Processes of Care for Patients with End-Stage Renal Disease in the United States. American Journal of Kidney Diseases. 2018 Jul: 72(1): 19-29.
Augustine JJ, Arrigain S, Balabhadrapatruni K, Desai N, Schold JD. Significantly Lower Rates of Kidney Transplantation among Candidates Listed with the Veterans Administration: a National and Local Comparison. Journal of the American Society of Nephrology. 2018 Oct; 29(10): 2574-82.
Husain SA, Brennan C, Michelson A, Tsapepas D, Schold JD, Mohan S. Patients Prioritize Waitlist over Post-Transplant Outcomes when Evaluating Kidney Transplant Centers. American Journal of Transplantation. 2018 Nov; 18(11): 2781-90.
Cooper M, Formica R, Friedewald J, Hirose R, O’Connor K, Mohan S, Schold J, Axelrod D, Pastan S. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards. Clinical Transplantation. 2019 Jan; e13419.
Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED. Dramatic Secular Changes in Prognosis for Kidney Transplant Candidates in the United States. American Journal of Transplantation. 2019 Feb; 19(2): 414-24.
Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY. Characteristics and Outcomes of Patients with Aortic Stenosis and Chronic Kidney Disease. Journal of the American Heart Association. 2019 Feb; 8(3): e009980.
Schold JD, Patzer RE, Pruett TL, Mohan S. Quality Metrics in Kidney Transplantation: Current Landscape, Trials and Tribulations, Lessons Learned and a Call for Reform. American Journal of Kidney Diseases (in press).
Chandraker A, Andreoni KA, Gaston RS, Gill J, Locke JE, Mathur AK, Norman DJ, Patzer RE, Rana A, Ratner LE, Schold JD, Pruett TL. Time for Reform in Transplant Program Specific Reporting – AST/ASTS Transplant Metrics Taskforce. American Journal of Transplantation (in press).
The Cleveland Clinic Center for Populations Health Research (CPHR), established in 2017, recently announced the first round of projects selected for collaboration. This support is intended to help physicians and investigators leverage Cleveland Clinic’s large and diverse patient population to generate insights about why groups of people or communities are more or less likely to be healthy, and how this can be harnessed and transformed into clinical or community interventions that improve health outcomes at the population level.
A new Cleveland Clinic populations health study shows that residential life expectancy is associated with processes of care and health outcomes among patients with end-stage renal disease (ESRD). The findings suggest that community life expectancy may be an important factor to consider when developing personalized care and treatment plans for patients.
Jesse Schold, PhD, Quantitative Health Sciences, has been named director of Cleveland Clinic's new Center for Populations Health Research (CPHR), which will be housed in the Lerner Research Institute.